[breadcrumb_custom]

ASMB’s Stock Market Pendulum: Swinging Between Gains and Losses

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a gain of 5.35%.However, over the last six months, we can see a stronger performance of -18.49%. Over the last 30 days, the price of ASMB has fallen by 5.14%. And in the last five days, it has fallen by -8.75%.

Assembly Biosciences Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $1.67 on 10/17/23 and a low of $0.64 for the same time frame on 11/22/23.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

52-week price history of ASMB Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Assembly Biosciences Inc’s current trading price is -48.26% away from its 52-week high, while its distance from the 52-week low is 34.79%. The stock’s price range during this period has varied between$0.64 and $1.67. The Assembly Biosciences Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.48 million for the day, a figure considerably higher than their average daily volume of 0.49 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Assembly Biosciences Inc (ASMB) has experienced a quarterly decline of -3.45% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 56.84M and boasts a workforce of 68 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8296, with a change in price of -0.0512. Similarly, Assembly Biosciences Inc recorded 1,386,833 in trading volume during the last 100 days, posting a change of -5.63%.

ASMB’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ASMB stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.00.

ASMB Stock Stochastic Average

As of today, Assembly Biosciences Inc’s raw stochastic average for the last 50 days stands at 39.19%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 27.34%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 56.31% and 65.36%, respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts